Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case study

Nonalcoholic steatohepatitis (NASH) is a major cause of liver fibrosis with increasing prevalence worldwide. Currently there are no approved drugs available. The development of new therapies is difficult as diagnosis and staging requires biopsies. Consequently, predictive plasma biomarkers would be...

Descripción completa

Detalles Bibliográficos
Autores principales: Veyel, Daniel, Wenger, Kathrin, Broermann, Andre, Bretschneider, Tom, Luippold, Andreas H., Krawczyk, Bartlomiej, Rist, Wolfgang, Simon, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987209/
https://www.ncbi.nlm.nih.gov/pubmed/31992752
http://dx.doi.org/10.1038/s41598-020-58030-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987209/
https://www.ncbi.nlm.nih.gov/pubmed/31992752
http://dx.doi.org/10.1038/s41598-020-58030-6

Ejemplares similares